NZ577075A - Modulation of prostaglandin/cyclooxygenase metabolic pathways - Google Patents

Modulation of prostaglandin/cyclooxygenase metabolic pathways

Info

Publication number
NZ577075A
NZ577075A NZ577075A NZ57707507A NZ577075A NZ 577075 A NZ577075 A NZ 577075A NZ 577075 A NZ577075 A NZ 577075A NZ 57707507 A NZ57707507 A NZ 57707507A NZ 577075 A NZ577075 A NZ 577075A
Authority
NZ
New Zealand
Prior art keywords
epia
group
inflammatory
hydroxy
pgj2
Prior art date
Application number
NZ577075A
Other languages
English (en)
Inventor
Ernst Wulfert
Original Assignee
Hunter Fleming Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunter Fleming Ltd filed Critical Hunter Fleming Ltd
Priority claimed from PCT/GB2007/004584 external-priority patent/WO2008065408A2/en
Publication of NZ577075A publication Critical patent/NZ577075A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ577075A 2006-11-30 2007-11-29 Modulation of prostaglandin/cyclooxygenase metabolic pathways NZ577075A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86787306P 2006-11-30 2006-11-30
GB0623971A GB0623971D0 (en) 2006-11-30 2006-11-30 Modulation of prostaglandin/cyclooxygenase metabolic pathways
PCT/GB2007/004584 WO2008065408A2 (en) 2006-11-30 2007-11-29 Modulation of prostaglandin/cyclooxygenase metabolic pathways

Publications (1)

Publication Number Publication Date
NZ577075A true NZ577075A (en) 2012-01-12

Family

ID=37671641

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ577075A NZ577075A (en) 2006-11-30 2007-11-29 Modulation of prostaglandin/cyclooxygenase metabolic pathways

Country Status (9)

Country Link
CN (1) CN101594861B (es)
DK (1) DK2097079T3 (es)
ES (1) ES2390182T3 (es)
GB (1) GB0623971D0 (es)
NZ (1) NZ577075A (es)
PT (1) PT2097079E (es)
RS (1) RS52453B (es)
RU (1) RU2448712C2 (es)
SI (1) SI2097079T1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI713972B (zh) * 2019-01-14 2020-12-21 大江生醫股份有限公司 改善呼吸道健康之益生菌株及其組合物與用途
TWI692359B (zh) * 2019-02-25 2020-05-01 大江生醫股份有限公司 乳酸菌的代謝產物及其用於護肺的用途
CN111777613A (zh) * 2019-04-03 2020-10-16 中国药科大学 嘧啶二酮并吲哚和吡啶酮并吲哚类化合物的制备及用途
US20220202774A1 (en) * 2019-04-09 2022-06-30 Neurobit Science Co., Ltd. Pharmaceutical composition for prevention or treatment of spinal cord injury or spinal stenosis
CN111394289B (zh) * 2019-12-20 2021-06-11 合肥康诺生物制药有限公司 一种基因工程菌及其应用，生产前列腺素e2的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
GB2363984A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
GB2378898A (en) * 2001-08-14 2003-02-26 Hunter Fleming Ltd Prophylactic and therapeutic use of hydroxysteroids
FR2829697B1 (fr) * 2001-09-14 2004-03-19 Mayoly Spindler Lab Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin

Also Published As

Publication number Publication date
PT2097079E (pt) 2012-09-24
SI2097079T1 (sl) 2012-10-30
ES2390182T3 (es) 2012-11-07
RU2009124917A (ru) 2011-01-10
GB0623971D0 (en) 2007-01-10
RU2448712C2 (ru) 2012-04-27
DK2097079T3 (da) 2012-10-01
RS52453B (en) 2013-02-28
CN101594861B (zh) 2013-06-12
CN101594861A (zh) 2009-12-02

Similar Documents

Publication Publication Date Title
CA2807149C (en) Novel treatment of prostate carcinoma
US20130023504A1 (en) Modulation of Prostaglandin/Cyclooxygenase Metabolic Pathways
Lechuga et al. Estrogen replacement therapy in ovariectomized nonpregnant ewes stimulates uterine artery hydrogen sulfide biosynthesis by selectively up-regulating cystathionine β-synthase expression
US20070111973A1 (en) Treatment of tumours
NZ577075A (en) Modulation of prostaglandin/cyclooxygenase metabolic pathways
Cutie et al. In vitro and in vivo roles of glucocorticoid and vitamin D receptors in the control of neonatal cardiomyocyte proliferative potential
EP2219652B1 (en) Phospholipid compositions and uses thereof
Singh et al. Development and evaluation of animal models for sex steroid deficient dry eye
JP2010511028A5 (es)
Shi et al. Research advances in drug therapy of endometriosis
Zaib et al. Analyzing the challenges, consequences, and possible treatments for polycystic ovary syndrome
JP2008536808A (ja) プロゲステロン受容体による神経変性疾患の調節
Isaacs et al. Testosterone and the prostate
JP2004524325A (ja) 良性及び／または悪性腫瘍の治療のためのステロイド誘導体の使用
AU2002237613A1 (en) Use of steroid derivatives for the treatment of a benighn and/or malignant tumour
Wiren et al. Androgens and bone: basic aspects
Wiren Androgens receptor expression and steroid action in bone
US20240238310A1 (en) Modulation of sex steroid hormone production and activity for treating and preventing hernias
Pasqualini et al. Recent advances on the action of estrogens and progestogens in normal and pathological human endometrium
WO2008039482A2 (en) Methods and compositions for cancer prevention and treatment
Saribas et al. Ellagic acid increases implantation rates with its antifibrotic effect in the rat model of intrauterine adhesion
Tekmal et al. Aromatase Overexpression: Effect of Tissue Estrogen on Phenotypic and Biochemical Changes in Aromatase Transgenic Mice
Zhang Cell-cell interactions and gossypol's effects on cell functions of primary cultured human breast epithelial, stromal and adipose stromal cells

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
S38A Application for proceedings under section 38 (amendment of specification with leave of commissioner)

Free format text: BY WAY OF CORRECTION

S38C Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 29 NOV 2017 BY COMPUTER PACKAGES INC

Effective date: 20140909

LAPS Patent lapsed